Does APREPITANT Cause Therapy non-responder? 219 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Therapy non-responder have been filed in association with APREPITANT (CINVANTI). This represents 3.9% of all adverse event reports for APREPITANT.
219
Reports of Therapy non-responder with APREPITANT
3.9%
of all APREPITANT reports
175
Deaths
216
Hospitalizations
How Dangerous Is Therapy non-responder From APREPITANT?
Of the 219 reports, 175 (79.9%) resulted in death, 216 (98.6%) required hospitalization, and 212 (96.8%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which APREPITANT Alternatives Have Lower Therapy non-responder Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL